Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo
Fernanda Andrade(Universidade do Porto), Simó Schwartz(CIBBIM-Nanomedicine), Joaquin Seras‐Franzoso(Vall d'Hebron Institut de Recerca), Sara Montero‐Herradón(Universitat Autònoma de Barcelona), Zamira V. Díaz‐Riascos(Vall d'Hebron Institut de Recerca), Natalia García‐Aranda(Universitat Autònoma de Barcelona), Bruno Sarmento(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Francesc Martínez-Trucharte(Universitat Autònoma de Barcelona), Patricia Cámara‐Sánchez(Universitat Autònoma de Barcelona), Ibane Abasolo(Unknown), Marika Nestor(Uppsala University), Diego Arango(Unknown), Mireia Vilar-Hernández(Universitat Autònoma de Barcelona), Ana Boullosa(Universitat Autònoma de Barcelona), Diana Rafael(University of Lisbon)
Cited by 71
Related Papers
Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells
|British Journal of Cancer|2004|275
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases
|Advanced Drug Delivery Reviews|2013|237
Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
|PLoS ONE|2014|207
Bacterial Inclusion Bodies: Discovering Their Better Half
|Trends in Biochemical Sciences|2017|181
Bacterial inclusion bodies: making gold from waste
|Trends in biotechnology|2011|173